|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Asbestos-related benefit (costs), net | |||||
| Net gain (loss) on dispositions of assets | |||||
| Impairment of indefinite-lived intangible assets | |||||
| Operating profit (loss) | |||||
| Other expense, net: | |||||
| Interest expense | |||||
| Debt financing and related expenses | |||||
| Other income (expense), net | |||||
| Other expense, net | |||||
| Income (loss) before income taxes | |||||
| Income tax benefit (expense) | |||||
| Income (loss) from continuing operations | |||||
| Income from discontinued operations, net of income taxes | |||||
| Net income (loss) | |||||
| Basic earnings (loss) per share: | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Net income (loss) per share | |||||
| Weighted average common shares—basic | |||||
| Diluted earnings (loss) per share: | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Net income (loss) per share | |||||
| Weighted average common shares—diluted |
Loading...